Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2026

Segment Reporting

Schedule of activity of Company's segments


		For the Three Months Ended June 30,
		2026									2025
		Digital			Corporate/						Ophthalmic			Digital			Corporate/
		Assets			Other			Total			Technology			Assets			Other			Total

Revenue:
Revenue		$	357,693		$	—		$	357,693		$	—		$	—		$	—		$	—
Gross Profit			357,693			—			357,693			—			—			—			—
Less:
Research and Development:
Salaries and benefits			—			44,120			44,120			424,032			—			—			424,032
Direct clinical and non-clinical expenses			—			6,707			6,707			16,263			—			—			16,263
Facilities expenses			—			1,256			1,256			62,432			—			—			62,432
Non-cash stock based compensation expenses			—			4,187			4,187			157,291			—			—			157,291
Other expenses ⁽¹⁾			—			2,221			2,221			14,560			—			—			14,560
Realized gain - digital assets and digital assets receivable			(17,859,505)			—			(17,859,505)			—			—			—			—
Unrealized gain - digital assets			(16,939,634)			—			(16,939,634)			—			—			—			—
Unrealized loss - digital intangible assets receivable			367,251			—			367,251			—			—			—			—
Impairment loss - digital intangible assets			768,857			—			768,857			—			—			—			—
Net gain on derivative instruments			(112,032)			—			(112,032)			—			—			—			—
Recovery of credit losses			(909,842)			—			(909,842)			—			—			—			—
Segment (income) loss			(35,042,598)			58,491			(34,984,107)			674,578			—			—			674,578
Reconciling Items
Selling, general and administrative expense ⁽²⁾			—			3,918,592			3,918,592			—			—			7,678,704			7,678,704
Impairment of right-of-use assets			—			57,773			57,773			—			—			—			—
Other expense, net ⁽³⁾			—			56,779			56,779			—			—			337,637			337,637
Net Income (Loss)		$	35,042,598		$	(4,091,635)		$	30,950,963		$	(674,578)		$	—		$	(8,016,341)		$	(8,690,919)


		For the Six Months Ended June 30,
		2026									2025
		Digital			Corporate/						Ophthalmic			Digital			Corporate/
		Assets			Other			Total			Technology			Assets			Other			Total

Revenue:
Revenue		$	601,964		$	—		$	601,964		$	14,720		$	—		$	—		$	14,720
Less:
Cost of revenue			—			—			—			(48)			—			—			(48)
Gross Profit			601,964			—			601,964			14,672			—			—			14,672
Less:
Research and Development:
Salaries and benefits			—			167,226			167,226			844,032			—			—			844,032
Direct clinical and non-clinical expenses			—			67,548			67,548			88,920			—			—			88,920
Facilities expenses			—			13,044			13,044			133,269			—			—			133,269
Non-cash stock based compensation expenses			—			43,121			43,121			221,968			—			—			221,968
Supplies and materials			—			—			—			25,130			—			—			25,130
Other expenses ⁽¹⁾			—			6,101			6,101			34,302			—			—			34,302
Depreciation expense			—			48,215			48,215			—			—			—			—
Realized gain - digital assets and digital assets receivable			(21,483,269)			—			(21,483,269)			—			—			—			—
Unrealized gain - digital assets			(27,913,613)			—			(27,913,613)			—			—			—			—
Impairment loss - digital intangible assets			2,000,525			—			2,000,525			—			—			—			—
Net gain on derivative instruments			(151,433)			—			(151,433)			—			—			—			—
Recovery of credit losses			(405,331)			—			(405,331)			—			—			—			—
Segment (income) loss			(48,555,085)			345,255			(48,209,830)			1,347,621			—			—			1,347,621
Reconciling Items
Selling, general and administrative expense ⁽²⁾			—			8,412,196			8,412,196			—			—			10,051,026			10,051,026
Impairment of right-of-use assets			—			57,773			57,773			—			—			—			—
Other expense, net ⁽³⁾			—			(51,652)			(51,652)			—			—			790,477			790,477
Net Income (Loss)		$	48,555,085		$	(8,763,572)		$	39,791,513		$	(1,332,949)		$	—		$	(10,841,503)		$	(12,174,452)

(1)	Other research and development expenses include outsourced engineering and IT systems used for research and development.

(2)	Selling, general and administrative expenses primarily include professional fees, general and administrative compensation expenses, general strategic consulting, Nasdaq/SEC fees, insurance and facilities expenses.

(3)	Other (income) expense, net includes interest income, interest expense and gain on extinguishment of liabilities.

Schedule of segment assets


		June 30, 2026									December 31, 2025
		Digital			Corporate/						Ophthalmic			Digital			Corporate/
		Assets			Other			Total			Technology			Assets			Other			Total
Segment Assets
Cash		$	—		$	9,637,216		$	9,637,216		$	—		$	—		$	6,310,878		$	6,310,878
Digital assets			99,840,797			—			99,840,797			—			43,872,033			—			43,872,033
All other assets			—			3,660,905			3,660,905			132,652			—			1,448,693			1,581,345
Total Assets		$	99,840,797		$	13,298,121		$	113,138,918		$	132,652		$	43,872,033		$	7,759,571		$	51,764,256